Skip to main content

Claudin-6 CAR T cells

Claudin-6 is largely silent in adult tissue and re-expressed on some solid tumours. That pattern makes it a candidate target for engineered T cells that would otherwise have too little healthy-tissue margin.

  • RegistryNCT04503278
  • PhasePhase 1/2
  • StatusActive, not recruiting
  • ConditionCLDN6+ solid tumours
  • SponsorBioNTech
How a claudin-6 CAR T cell worksNCT04503278

The drug

What is being tested.

Chimeric antigen receptor T cells are T cells given a synthetic receptor so they can recognise a surface protein without MHC. The hard problem in solid tumours is choosing a protein the cancer has and healthy adult tissue does not.

Claudin-6 is an oncofetal tight-junction protein: present in development, mostly off in adult organs, and re-expressed on subsets of testicular, ovarian, and other solid tumours. The CAR is directed at that protein.

Some protocols add a CLDN6-encoding mRNA vaccine after infusion. The idea is to present the same antigen in the lymph node and keep the engineered cells expanded — a CAR plus a boost, rather than a CAR alone.

The study

How the trial runs.

BNT211 is a first-in-human program of CLDN6-directed CAR T cells, with or without a CLDN6 mRNA vaccine, in patients whose tumours express claudin-6. Early cohorts map dose, lymphodepletion, and whether the vaccine arm changes persistence.

Live record on ClinicalTrials.gov →

Eligibility

Who the study is looking for.

  • Solid tumour with CLDN6 expression, as defined by the protocol assay
  • Adequate organ function for lymphodepletion and cell therapy
  • No contraindication to CAR T manufacturing or infusion

Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.

For you, or someone you love

Whether or not this trial is the one, bring AI into your corner.

A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.

Start your 7-day free trial

Then $9 a month. Cancel anytime.

  • Every record in one place

    Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.

  • Read in plain words

    Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.

  • Ready for every appointment

    Ask about your own file, and walk in with questions for your oncologist or the trial team.

  • Your people, in the loop

    Share one profile with the family helping you, and with your doctors.

Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.

How these trials work: what Phase 1 actually is · common questions Not clinical evidence.